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Abstract  
 
Pancreatic β-cells release insulin in response to elevation of glucose from basal (4-7 
mM) to stimulatory (8-16 mM) levels.  Metabolism of glucose by the β-cell results in the 
production of low levels of reactive oxygen intermediates (ROI), such as hydrogen 
peroxide (H2O2), a newly recognized coupling factor linking glucose metabolism to 
insulin secretion. However, high and toxic levels of H2O2 inhibit insulin secretion. 
Menadione, which produces H2O2 via redox cycling mechanism in a dose-dependent 
manner, was investigated for its effect on β-cell metabolism and insulin secretion in INS-
1 832/13, a rat β-cell insulinoma cell line, and primary rodent islets. Menadione-
dependent redox cycling and resulting H2O2 production under stimulatory glucose 
exceeded several-fold those reached at basal glucose. This was paralleled by a 
differential effect of menadione (0.1-10 µM) on insulin secretion, which was enhanced at 
basal, but inhibited at stimulatory glucose. Redox cycling of menadione and H2O2 
formation was dependent on glycolytically-derived NADH, as inhibition of glycolysis and 
application of non-glycogenic insulin secretagogues did not support redox cycling.  In 
addition, activity of plasma membrane electron transport, a system dependent in part on 
glycolytically-derived NADH, was also inhibited by menadione. Menadione-dependent 
redox cycling was sensitive to the NQO1 inhibitor dicoumarol and the flavoprotein 
inhibitor diphenylene iodonium, suggesting a role for NQO1 and other oxidoreductases 
in this process.  These data may explain the apparent dichotomy between the 
stimulatory and inhibitory effects of H2O2 and menadione on insulin secretion.   
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Introduction 
Pancreatic β-cells, which comprise more than 75% of the mass of the islets of 
Langerhans, release insulin in response to elevation of blood glucose concentrations 
from fasting, basal levels (4-6 mM) to post-meal, stimulatory levels (7-16 mM) (reviewed 
in (Jitrapakdee et al., 2010)).  Insulin secretion from pancreatic β-cells is contingent 
upon glucose metabolism. Extracellular glucose is immediately sensed by the β-cell as 
it enters the cell via the low affinity high capacity GLUT-2 transporter (reviewed in 
(Thorens, 2004) and is rapidly metabolized via glycolysis.  Pyruvate, the end product of 
glycolysis, enters the TCA cycle via both pyruvate carboxylation and decarboxylation 
routes, resulting in the increase in activity of cytosolic and mitochondrial metabolic 
pathways. This results in an increase of the ATP/ADP ratio, closure of the KATP 
channels, depolarization of the plasma membrane, calcium influx, and enhanced 
pyruvate cycling coupled to the production of NADPH (reviewed in (Jensen et al., 
2008)). All these processes work in synchrony to trigger insulin release from the 
pancreatic β-cell. 
Glucose metabolism itself is responsible for the generation of low, physiological 
levels of reactive oxygen intermediates (ROI) (Bindokas et al., 2003) such as H2O2 (Pi 
et al., 2007), a pro-oxidant that is generated from superoxide by superoxide dismutase 
or spontaneous dismutation.  -cells express relatively low levels of antioxidant 
enzymes, such as superoxide dismutase, catalase, and glutathione peroxidase when 
compared with other tissues (Tiedge et al., 1997; Robertson and Harmon, 2007), 
suggesting that β-cells might be more sensitive than other cell types to both oxidant 
signaling as well as oxidative insult. Indeed, at high levels (.05 and 1 mM), H2O2 is 
known to interfere with glucose metabolism in -cells, hyperpolarize the plasma 
membrane, lower the ATP/ADP ratio, and block glucose-stimulated insulin release 
(Krippeit-Drews et al., 1999; Maechler et al., 1999; Sakai et al., 2003; Rebelato et al., 
2010) and it is thought that chronic exposure to nonphysiologically high levels of 
glucose causes β-cell toxicity through the generation of oxidative damage (Evans et al., 
2002; Piro et al., 2002; Evans et al., 2003; Robertson et al., 2003).  However, attempts 
to bolster antioxidant defense in -cells through overexpression of antioxidant enzymes ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
or direct treatment with antioxidants reduced the ability of -cells to release insulin in 
response to stimulatory glucose (Pi et al., 2007; Leloup et al., 2009) and treatment of -
cells with low doses of H2O2 (1-4 M) stimulated insulin secretion in the presence of 
basal glucose levels (Pi et al., 2007).  
Menadione is an exogenous quinone, similar in structure to ubiquinone, the 
membrane-bound electron carrier.  Like other quinones, menadione can undergo redox 
cycle, which involves enzymatic reduction by cellular oxidorecuctases, followed by 
autooxidation in the presence of molecular oxygen, generating superoxide (O2
-)  and 
subsequently H2O2 (Bolton et al., 2000).To date, the effects of quinones such as 
menadione on β-cell metabolism and insulin secretion have not been investigated in 
sufficient depth.  Although menadione (1 mM) was shown to stimulate insulin secretion 
at basal glucose (MacDonald, 1991b), this dose is quite toxic and the reported insulin 
secretion may represent lysis of the cells and subsequent release of insulin from 
damaged cells, as the viability of cells exposed to this level of menadione was not 
addressed in that study.  In contrast, other studies reported that menadione at 10 and 
50 M caused a decrease in insulin secretion at stimulatory glucose (Malaisse et al., 
1978b; MacDonald, 1991b).  Thus, these studies suggest that menadione exerts 
opposite effects on insulin release depending on the level of glucose present and this 
study was undertaken to elucidate basis of this dichotomy.   
The effects of menadione on insulin secretion may be due in part to redox cycling 
and the consequent generation of H2O2.  In contrast to the transient exposure to H2O2 
that occurs following the direct addition of H2O2 to the cells, the exposure of cells to 
menadione allows the sustained generation of H2O2 in a dose dependent manner that 
might better reflect the physiological release of H2O2 during intermediary metabolism of 
glucose (Bindokas et al., 2003).  Therefore, a wide range of H2O2 levels can be 
produced dependent on the dose of menadione (Adam et al., 1990), at levels similar to 
or greater than those involved in cellular signaling.  In the current work, we employed 
menadione at the sub-toxic dose range (1-10 M) (Tiedge et al., 1998) to generate a 
controlled and sustained release of H2O2 in the INS-1 832/13 insulinoma cell line, which 
exhibits key metabolic features of native islet β-cells and presents robust insulin 
secretion in response to elevation in glucose levels from 2 (basal, non-stimulatory) to 16 ACCEPTED MANUSCRIPT
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(stimulatory) mM (Hohmeier et al., 2000).   We demonstrate that in both INS-1 832/13 
cells and in isolated pancreatic islets, menadione-stimulated H2O2 formation is 
supported by the application of glucose, but not any other metabolic fuels shown to 
stimulate insulin secretion, such as methyl-succinate, methyl-pyruvate, or 
glutamine/leucine. Furthermore, we demonstrate that the level of applied glucose 
dictates the level of H2O2 produced via redox-cycling under a given dose of menadione. 
This information provides mechanistic insight into menadione’s dichotomous effect on 
insulin secretion:  under stimulatory glucose conditions, the greater amount of H2O2 
produced negatively affects the insulin secretory pathway, whereas the lower amount 
produced at basal glucose stimulates insulin secretion.   
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Methods 
 
Reagents.  10-acetyl-3,7-dihydroxyphenoxazine (AMPLEX-RED) was obtained from 
Invitrogen (Carlsbad, CA).  Horseradish peroxidase, quinones, and all other chemicals 
were purchased from Sigma Aldrich (St. Louis, MO).   
 
Cells.  Clonal INS-1 832/13 cells were provided by Dr. Christopher Newgard (Duke 
University) and were maintained and cultured as described previously (Hohmeier and 
Newgard, 2004).  KRB buffer (140 mM NaCl, 30 mM HEPES pH 7.4, 4.6 mM KCl, 1 mM 
MgSO4, 0.15 mM Na2HPO4, 0.4 mM KH2PO4, 5 mM NaHCO3, and 2 mM CaCl2), 
supplemented with glucose as indicated in each experiment, used in place of cell 
culture medium for most assays.  For treatments greater than two hours, KRB was 
supplemented with 0.5% w/w bovine serum albumin.  All experiments with INS-832/13 
cells were performed at ~90% confluence in 96 well plates (H2O2 studies) or 48-well 
plates (insulin secretion studies).   
 
Animals and Islet isolation. All procedures were performed in accordance with the 
Institutional Guidelines for Animal Care, in compliance with the United States Public 
Health Service Regulations.  Male CD-1 mice (Charles River) were euthanized by 
Halothane. Pancreatic islets were isolated by collagenase (Roche) digestion, as 
previously described (Gray et al., 2011) and used for experiments following overnight 
culture.  
 
Hydrogen peroxide assay.  The Amplex Red/horseradish peroxidase assay was used to 
quantify the production of H2O2 as previously described with minor modifications (Gray 
et al., 2007).  Reaction mixes contained 25 M Amplex Red and 1 U/ml horseradish 
peroxidase in KRB buffer in the presence of glucose or other fuels as indicated in each 
experiment.  Fluorescence was monitored using a SpectraMax M5 multi-mode 
microplate reader (Molecular Devices, Sunnyvale, CA).  The production of H2O2 was 
quantified by measuring the rate of increase in fluorescence (540 nm excitation, 595 nm ACCEPTED MANUSCRIPT
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emission) due to conversion of Amplex Red to Resorufin by horseradish peroxidase in 
the presence of adherent cells.  The rate of H2O2 formation was calculated based on a 
standard curve constructed with H2O2 in a concentration range of 0.5-16 M.   
 
PMET activity assay. PMET activity assays were performed as previously described 
with minor modifications (Gray et al., 2011). Following a 40 min preincubation in KRB 
buffer supplemented with 2 mM glucose, INS-1 832/13 cells (96-well plates) were 
exposed to the indicated concentrations of glucose, menadione, or H2O2, and incubated 
in the presence of 250 mM WST-1 or 250 mM ferricyanide for 3 hr.  The presence of the 
intermediate electron carriers 1-mPMS and CoQ1 was obligatory for WTS-1 and 
ferricyanide reduction, respectively (Gray et al., 2011).  Reduction of WST-1 to WST-1-
formazan and the reduction of ferricyanide (Fe
3+) to ferrocyanide (Fe
2+) was monitored 
by the change in absorbance at 450 and 420 nm, with reference absorbances at 650 or 
500 nm, respectively using a SpectraMax M5 multi-mode microplate reader (Molecular 
Devices, Sunnyvale, CA).   
 
Insulin secretion.  INS-1 832/13 cells were pre-incubated for 1 hr in the presence of 2 
mM glucose in KRB buffer.  The amount of released insulin was determined after 60 
min of static incubation in the presence of indicated amount of glucose and/or H2O2 or 
menadione using an ELISA kit (Alpco Diagnostics, Salem, NH).  Data were normalized 
for protein content determined by the Micro-BCA Protein Assay kit (Pierce, Rockford, 
IL).   
 
Cell viability and toxicity assays.  All assays purchased from Promega (Madison, WI) 
were performed according to manufacturer's instructions using a SpectraMax M5 multi-
mode microplate reader (Molecular Devices, Sunnyvale, CA).  CellTiter-Blue assays 
(cat # G8081) were performed by the addition of 20 L of CellTiter-Blue dye to wells 
containing cell culture media, and measured by the increase in fluorescence (560 nm 
excitation, 590 nm emission).  Increasing concentrations of glucose increased CellTiter-
Blue activity (data not shown); therefore, all experiments were performed with equal 
concentrations of glucose.  The trypan blue exclusion was performed as previously ACCEPTED MANUSCRIPT
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described (Grankvist et al., 1979).  The GSH/GSSG-Glo assay (cat #V6611, Promega) 
was used to quantify oxidized glutathione and total glutatione (oxidized and reduced).    
 
Statistical analysis.  Data are expressed as means ± standard deviation.  Significance 
was determined for multiple comparisons using 1 or 2-way Analysis of Variance 
(ANOVA) followed by the Bonferroni post test (Neter et al., 1990). 
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Results 
Insulin secretion is the primary function of pancreatic -cells.  A significant 
increase in insulin output occurs when glucose is raised from basal, non-stimulatory 
levels (2-4 mM) to stimulatory levels (10-16 mM).  Previous studies showed that 
treatment of intact islets with either H2O2, or 10 M menadione, whose intracellular 
metabolization generates H2O2, blunted insulin secretion under stimulatory glucose 
(Malaisse et al., 1978a; Rebelato et al., 2010). However, other studies showed that low 
levels of H2O2 stimulated insulin secretion at basal glucose levels (Pi et al., 2007).  No 
study has been performed so far in which menadione’s effect was tested under the 
complete range of glucose concentrations and therefore consensus regarding the effect 
of menadione and its redox product H2O2 on -cell metabolism are lacking. Because 
menadione induces the production of H2O2 in cells, we tested the effect of a dose 
response of menadione in INS-1 832/13 cells under both basal (2 mM) and stimulatory 
(16 mM) glucose levels.  A basal glucose level of 2 mM was used since these cells are 
left-shifted in their glucose dose-response (Poitout et al., 1996). As previously shown 
(Malaisse et al., 1978b), elevated levels of menadione (10 uM) blunted secretion under 
stimulatory (16 mM) glucose levels (Figure 1A).  In contrast, menadione (1-10 M) 
stimulated insulin secretion at 2 mM glucose in a dose dependent manner (Figure 1A), 
consistent with the reported  H2O2 –dependent insulin release at non stimulatory 
glucose (Pi et al., 2007) (Figure 1B).  To investigate if menadione-dependent formation 
of H2O2 is responsible for the observed increased secretion, cells were treated with 
pegylated catalase (PEG-CAT), a membrane permeable H2O2 scavenger.  PEG-CAT 
blunted both glucose-stimulated insulin secretion (Figure 1C) and menadione-stimulated 
insulin secretion (Figure 1D), suggesting that H2O2 is a common factor required for 
insulin secretion.   
Menadione redox cycling is dependent on both NADPH and NADH as 
substrates.  Pancreatic islets β-cells respond to an increase in glucose concentration 
with an increase in the reduced-to-oxidized adenine nucleotide ratio 
(NAD(P)H/NAD(P)
+) (Malaisse et al., 1979; Capito et al., 1984; Sener and Malaisse, 
1987; Heart et al., 2007). Therefore we investigated the redox cycling of menadione and ACCEPTED MANUSCRIPT
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similar quinones in β-cells under basal (2 mM) or stimulatory (16 mM) concentrations of 
glucose by measuring the rate of H2O2 formation.  Menadione stimulated a dose-
dependent increase in H2O2 formation at both basal and stimulatory glucose (Figure 
2A).  In a dose range of 1-30 M, stimulatory (16 mM) glucose increased the rate of 
H2O2 formation as much as 4-fold over that of basal (2 mM) glucose. Similar results 
were found in isolated mouse islets, where menadione-dependent H2O2 production at 
16 mM glucose reached 151 ± 15.5% of that at 4 mM glucose. Other quinones of similar 
chemical structure also showed elevated redox cycling at stimulatory glucose (Figure 
2B-2F), while paraquat, a non-quinone redox cycling chemical, failed to stimulate H2O2 
formation (data not shown).  Higher passage number of INS-1 832/13 cells also resulted 
in decreased H2O2 formation in response to menadione treatment (data not shown).  
This is consistent with the passage-dependent decrease in metabolic function and 
glucose-stimulated insulin secretion reported for various β-cell lines (Zhang et al., 1989; 
Clark et al., 1990), including INS-1 cells (Ramanadham et al., 2000). 
The first step of glucose metabolism in β-cells is its phosphorylation by 
glucokinase, whose KM for glucose is approximately 8.7 mM (Meglasson and 
Matschinsky, 1986).  To test whether stimulation of the redox cycling of menadione by 
glucose demonstrates a similar Km, INS-1 832/13 cells were treated with 10 M 
menadione in the presence of glucose (2-84 mM) (Figure 3A). A dose-dependent 
increase in H2O2 was found with a Km of 11.1 mM, similar to that of glucokinase.  
Treatment with the non-metabolizable glucose analog 2-deoxy-D-glucose failed to 
stimulate H2O2 formation (Figure 3A).  Alloxan is a diabetogenic agent that functions in 
part through inhibition of glucokinase, blocking glycolysis in β-cells (Lenzen et al., 
1988).  Pretreatment of β-cells with alloxan blunted menadione redox cycling at both 
basal and stimulatory levels of glucose, suggesting that glycolysis is required for 
menadione stimulated H2O2 formation (Figure 3B).   
In addition to glucose, a number of other metabolic fuels have been shown to 
stimulate insulin secretion.  These fuels primarily function through the direct stimulation 
of mitochondrial metabolism.  Methyl succinate is metabolized via direct entry to 
mitochondrial complex 2 (MacDonald and Fahien, 1990); methyl pyruvate is thought to ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
be metabolized, after removal of the methyl group, directly by the mitochondria (Jijakli et 
al., 1996); and the combination of glutamine and leucine activates mitochondrial 
glutamate dehydrogenase (Fahien et al., 1988).  While menadione redox cycling in the 
presence of 10 or 16 mM glucose was increased more than two-fold in INS-1 832/13 
cells (Figure 4), all of the non-glycogenic secretagogues, applied at concentrations 
shown to stimulate metabolism and insulin secretion, failed to support menadione-
mediated redox cycling.  Since these other fuels are not metabolized via glycolysis, 
these data suggest that glycolytically-derived NADH, rather than mitochondrially-derived 
NAD(P)H, is important to mediate menadione redox cycling by glucose.  Furthermore, 
methyl pyruvate, a membrane-permeable form of pyruvate, actually inhibited 
menadione-mediated redox cycling, consistent with pyruvate-mediated scavenging of 
H2O2 (reviewed in (Kao and Fink, 2010)). 
Menadione-mediated redox cycling is dependent upon the availability of NADH or 
NADPH. NADH and NADPH are generated during glucose metabolism by reduction of 
their oxidized counterparts, NAD
+ and NADP
+, which results in an increase in reduced-
to-oxidized nucleotides ratios (NAD(P)H/NAD(P)
+) following the rise in glucose 
concentration (Malaisse et al., 1979; Capito et al., 1984; Sener and Malaisse, 1987; 
Ivarsson et al., 2005; Heart et al., 2007). Any processes which further increase the 
reduced nucleotide pool have the potential to enhance redox cycling. The mitochondrial 
inhibitors cyanide (0.3-5 mM) and antimycin A (0.1-10 nM) stimulated menadione-
mediated H2O2 formation at both basal and stimulatory glucose in a dose-dependent 
manner (Figure 5).  Since glycolytically-derived NADH reoxidation is prevented when 
mitochondrial function is compromised, mitochondrial inhibitors may increase 
menadione redox cycling by increasing the available NADH pool.  In addition to 
mitochondrial metabolism, plasma membrane electron transport (PMET) is another 
mechanism by which cytoplasmic NADH and NADPH can be oxidized.  In PMET, 
electrons are passed from cytosolic NAD(P)H through the plasma membrane to 
extracellular acceptors (reviewed in (Principe et al., 2011)).  Previous work showed that 
glucose stimulated PMET activity in a dose-dependent manner (Gray et al., 2011).  
Menadione was found to inhibit PMET in a dose-dependent manner (Figure 6A-6B).  
Since both PMET and menadione redox cycling consume NAD(P)H, menadione-ACCEPTED MANUSCRIPT
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mediated inhibition of PMET activity may be due in part the reduced level of NAD(P)H 
available.  Alternatively, H2O2 produced by menadione redox cycling might exert a toxic 
effect on the cells.  Although H2O2 (50 uM) was able to inhibit PMET activity (Figures 6C 
and 6D), the dose required to do this was much greater than the concentration of H2O2 
produced by menadione redox cycling, suggesting that it is direct competition for 
NAD(P)H that drives menadione-mediated inhibition of PMET activity.   
Menadione redox cycling is mediated by the action of quinone oxidoreductase 
enzymes (Bolton et al., 2000).  Multiple oxidoreductases are capable of supporting 
redox cycling of quinones, and the identity of these enzymes varies by cell type.  
Pancreatic islet homogenates were previously shown to contain quinone reductase 
activity (Malaisse et al., 1978a; MacDonald, 1991a).  NQO1 is a quinone 
oxidoreductase that is a component of the plasma membrane electron transport system 
in -cells (Gray et al., 2011).  Diphenylene iodonium (DPI), a flavoprotein inhibitor 
(Cross and Jones, 1986), was previously shown to block insulin secretion under 
stimulatory glucose levels in isolated rat islets (Morgan et al., 2009).  These authors 
suggested that DPI affected insulin secretion by modifying H2O2 levels.  Therefore, DPI 
and dicoumarol, an inhibitor of NQO1 (Hosoda et al., 1974), were tested for their ability 
to reduce menadione-mediated H2O2 formation in β-cells.  Both inhibitors caused a 
dose-dependent decrease in H2O2 formation (Figure 7A and 7B).   
Prolonged treatment with high and toxic levels of H2O2 are known to be 
detrimental to -cells.  INS-1 832/13 cells treated with H2O2 for 6 h experienced less 
toxicity in the presence of 16 mM glucose than at 2 mM glucose (Figure 8A), suggesting 
that glucose metabolism induces the production of biochemical pathways that protect 
against oxidative stress (Martens et al., 2005). Glucose exhibited a similar protective 
effect against menadione toxicity (Figures 8B and 8C), suggesting that, although 
menadione produces more H2O2 in the presence of glucose (Figure 3A), the glucose-
dependent increase in protection from oxidative stress also increases and protects 
against some of the H2O2 produced via redox cycling.  Interestingly, menadione-induced 
glutathione oxidation was not affected by the presence of glucose (Figure 8D), 
suggesting an alternative biochemical pathway might be exhibiting this protection.   
 ACCEPTED MANUSCRIPT
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Discussion 
 
Glucose metabolism in β-cells is prerequisite for insulin secretion.  Glucose 
equilibrates rapidly across the β-cell plasma membrane via the GLUT-2 transporter, and 
the rate of glycolysis is largely regulated via glucokinase, whose Km (8.7 mM) acts as a 
glucose sensor (reviewed in (Deeney et al., 2000)).  A physiological transient increase 
in extracellular glucose following a meal therefore leads to an increase in intermediary 
metabolism, and the concomitant production of low levels of ROI, namely H2O2, from a 
number of intracellular sources, such as the mitochondrial electron transport chain and 
cytosolic oxidoreductases via PMET (Pi et al., 2007; Leloup et al., 2009; Gray and 
Heart, 2010; Gray et al., 2011).  In contrast to chronic hyperglycemia (constantly 
elevated glucose levels seen in uncontrolled diabetes), which leads to the generation of 
high levels of ROI, responsible for oxidative stress (Robertson et al., 2003), low and 
physiological levels  of H2O2 generated during normal postprandial glucose metabolism 
recently received attention in the -cell field as a novel coupling factor linking glucose 
metabolism to insulin secretion (Pi et al., 2007).  Indeed, H2O2 is an important 
intracellular second messenger in many cell types (Kamata and Hirata, 1999).   
The effect of H2O2 on cellular metabolism and signaling is dependent on its 
concentration:  lower levels are generated as a consequence of intermediary 
metabolism under normal physiological situations and are involved in signaling, 
whereas higher levels are produced by oxidative insult such as exposure to high levels 
of ultraviolet radiation (Stone and Yang, 2006). This is supported by several indirect and 
direct observations:  β-cells express low levels of antioxidant enzymes, and treatment of 
β-cells with antioxidants blunts insulin secretion (Mikawa et al., 1997; Robertson and 
Harmon, 2007), suggesting that a low level of ROI, derived from the intracellular 
glucose metabolism is necessary to support insulin secretion.  Likewise, low doses of 
H2O2 (1-4 M) were shown to modestly stimulate insulin secretion at basal levels of 
glucose (Pi et al., 2007)(Figure 1).   
Previous studies of the effects of H2O2 on insulin secretion may have yielded 
conflicting results due to the nature of H2O2 generation and metabolism in cells and the 
experimental approaches used (reviewed in (Chance et al., 1979)).  A single addition of ACCEPTED MANUSCRIPT
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H2O2 at non-toxic levels involved in signaling will not mimic the physiological generation 
of H2O2.  Low doses of H2O2 given as a single addition (bolus) may be initially 
equivalent to physiological levels, but because H2O2 is rapidly degraded, the signal is 
immediately lost.  Attempting to overcome the degradation of H2O2 by using an elevated 
dose can trigger toxicity.  Neither method mimics the physiological situation in which a 
particular steady-state level of H2O2 is maintained through equal rates of production and 
degradation, such as that which occurs during elevation of postprandial glucose for 30-
60 minutes following a meal.  To mimic this physiological situation, H2O2 would have to 
be added in short intervals or delivered by perfusion to maintain steady state levels for 
that particular time period, an approach which is technically difficult to undertake.  An 
alternative approach would be to employ a well-defined system capable of generating 
the desired levels of peroxide in a continuous fashion inside the cell.    
Menadione is a redox cycling quinone shown by us (Figure 1) and others 
(Malaisse et al., 1978b; MacDonald, 1991b) to impact insulin secretion.  Like other 
quinones, menadione is reduced by cellular oxidoreductase enzymes, at the expense of 
NAD(P)H, and chemically reacts with molecular oxygen to produce O2
- which is 
subsequently converted to H2O2, spontaneously or through the action of superoxide 
dismutase (Bolton et al., 2000).  Addition of menadione to β-cells therefore results in the 
production of H2O2 in a sustained and dose-dependent manner that may better reflect 
its natural production as a second messenger (Figure 2).  The level of menadione-
mediated H2O2 formation was also directly proportional to the level of glucose, reaching 
an apparent maximum at about 20 mM glucose (Figures 2 and 3).  These results are 
consistent with the fact that pool size of reduced nucleotides NADH and NADPH, both 
of which serve as substrates for enzymes that redox cycle menadione (Bolton et al., 
2000), is dependent upon level of glucose. Furthermore, treatment of -cells with the 
non-metabolizable glucose analog 2-deoxy-D-glucose or treatment with the glucokinase 
inhibitor alloxan abolished the enhancing effect of glucose on menadione redox cycling, 
suggesting that glycolysis is critical for this process.  Likewise, several non-glycogenic 
insulin secretagogues which do not undergo glycolysis, methyl-succinate, methyl-
pyruvate, and the combination of glutamine/leucine, did not stimulate menadione redox 
cycling (Figure 4).  These data suggest that glycolysis is important for supporting fuel-ACCEPTED MANUSCRIPT
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supported increases in menadione redox cycling and H2O2 generation.  Interestingly, 
methyl pyruvate (10 mM and 16 mM), membrane permeable pyruvate analog, was 
found to suppress menadione redox cycling.  Pyruvate has been shown to act as an 
antioxidant and to scavenge H2O2 via nonenzymatic oxidative decarboxylation 
(Giandomenico et al., 1997).  Indeed, we found that methyl pyruvate reduces the H2O2 
levels in vitro, as determined by Amplex Red assay in cell-free solution (data not 
shown).   
NADH is produced in glycolysis via by reduction of NAD
+ by glyceraldehyde 
phosphate dehydrogenase. In order for glycolysis to continue, NADH must be re-
oxidized back to NAD
+.  Transport of NADH to the mitochondria for its re-oxidation back 
to NAD
+ is accomplished via the malate/aspartate and glycerol phosphate shuttles (Eto 
et al., 1999). We hypothesized that a glycolysis-dependent rise in NADH was 
responsible for enhanced redox cycling seen under stimulatory (16 mM) glucose. To 
test this, re-oxidation of glycolytically-derived NADH by the mitochondria was prevented 
by application of mitochondrial inhibitors.  Application of antimycin A and cyanide, which 
block complex 3 and 4 of the mitochondrial electron transport chain, resulted in a 
potentiation of menadione redox cycling at both 2 and 16 mM glucose (Figure 5).   
NADH may also be re-oxidized through trans-plasma membrane electron 
transport (PMET), a system that we’ve recently shown to be active within β-cells (Gray 
et al., 2011).  The PMET system oxidizes intracellular NADH and NADPH, while 
transferring electrons across the plasma membrane to extracellular targets (reviewed in 
(Gray and Heart, 2010)).  PMET is stimulated by an increase in the concentration of 
glucose, due to a glucose-dependent increase in reducing equivalents NADH and 
NADPH.  Menadione redox cycling, which consumes NAD(P)H, might be expected to 
inhibit PMET through competition for reduced substrates.  Indeed, we found that even 
low micromolar concentrations of menadione were able to inhibit PMET activity (Figure 
6).  Altogether, these data suggest that glycolytically-derived NADH is a major source 
for menadione mediated H2O2 formation in β-cells (Figure 9).   
  NADH and NADPH are capable of supporting menadione-dependent redox 
cycling by serving as substrates for oxidoreductase enzymes; many oxidoreductase 
enzymes are capable of using both nucleotides (Lind et al., 1990; Dicker and ACCEPTED MANUSCRIPT
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Cederbaum, 1991; Jaiswal, 2000; Xia et al., 2003).  Earlier studies showed that islets 
have quinone reductase activity and that islet lysates consume NADPH and NADH in 
response to treatment with substrates such as CoQ0 and menadione (Malaisse et al., 
1978a; MacDonald, 1991a).  NQO1 is a prototypical menadione reductase found in 
many cell types, including the -cell, where it is a component of the PMET pathway 
(Lind et al., 1990; Gray et al., 2011).   We demonstrated that dicoumarol, an inhibitor of 
NQO1, blocked menadione redox cycling in a dose-dependent manner (Figure 7A). 
DPI, a non-specific flavoprotein inhibitor, exerted a similar effect.   
  While short exposure (30 min) to menadione did not adversely affect cell viability 
(data not shown), prolonged treatment (6 h) with either H2O2 or menadione caused 
toxicity, as assessed by several cell viability assays.  Interestingly, in parallel to its 
capacity to facilitate redox cycling and menadione-dependent H2O2 production, 16 mM 
glucose increased cell viability in the presence of H2O2 or menadione (Figures 8A-8C), 
in agreement with the notion that glucose metabolism-dependent cytoprotective 
mechanisms are induced under physiologically elevated glucose (Martens and 
Pipeleers, 2009). Previous work showed that reduced glutathione is depleted in 
hepatocytes treated with menadione for 10 min (Gant et al., 1988), and we also 
observed a depletion of reduced glutathione in INS-1 832/13 cells treated with 
menadione (Figure 8D).  However, stimulatory glucose did not blunt this depletion, 
suggesting that glutathione is not responsible for the protection of INS-1 832/13 cells 
from menadione toxicity.  Future studies are underway to further investigate the 
mechanism of glucose-dependent protection from oxidative stress.   
   Altogether, our data suggest a mechanism for both menadione-mediated 
stimulation and inhibition of insulin secretion, summarized in Figure 9.  -cells may 
require a physiological level of H2O2, generated via intermediary metabolism, to enable 
the secretion of insulin.  However, the insulin secretory pathway is also sensitive to the 
toxic effects of H2O2.  Our study outlines a mechanism by which menadione affects  -
cell metabolism and insulin secretion, and demonstrates that the level of glucose is a 
critical determinant in the degree of redox cycling in the -cell.   
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Figure Legends: 
 
Figure 1.  Effect of menadione, H2O2, and catalase on insulin secretion in INS-1 
832/13 cells.  Insulin secretion was measured in cells exposed to 1-10 M menadione 
(A) or H2O2 (B) under both basal and stimulatory glucose. Effect of PEG-CAT on insulin 
secretion in response to 16 mM glucose and 10 µM menadione is shown in (C) and (D), 
respectively. Data, expressed as % insulin secretion obtained under 2 mM glucose 
(control), are means ± SE from 2-3 independent experiments performed in 
quadruplicate measurements.  
Figure 2. Glucose enhances redox cycling of quinones in INS-1 832/13 cells. Cells 
were treated with basal (2 mM) or stimulatory (16 mM) concentrations of glucose in the 
absence or presence of 0.1-100 M (A) menadione, (B) 1,4-naphthoquinone, (C) 1,2-
naphthoquinone, (D) 2-methoxy-1,4-naphthoquinone, (E) 9,10-phenanthroquinone, and 
(F) acenaphthene. The rate of H2O2 formation was performed as described in Methods. 
Data are means ± SD (n=3) and are representative of 2 independent experiments.  
Asterisks (*) indicate a significant different (p < 0.05) between 2 mM and 16 mM 
glucose-treated samples as determined by ANOVA followed by a Bonferroni 
comparison.   
Figure 3. Glucose-dependent  enhancement  of menadione redox cycling requires 
glycolysis.  (A) INS-1 832/13 cells were treated with menadione (10 M) and the 
indicated concentration of glucose or the non-metabolizable glucose analog 2-deoxy-D-
glucose. H2O2 production was determined as described in Methods.  4 mM glucose and 
above are significantly different from 2 mM glucose-treated sample (p < 0.05).  (B)  
Following a three hour pretreatment with alloxan, INS-1 832.13 cells were treated with 
glucose and/or menadione and analyzed for the production of H2O2 as in A.  Data are 
means ± SD (n=3) and are representative of 2 independent experiments.  Asterisk 
indicates significant difference for D-glucose treated samples from 2 mM treated 
controls (p < 0.05, one way ANOVA followed by a Bonferroni comparison).   ACCEPTED MANUSCRIPT
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Figure 4.  Effect of insulin secretory fuels on menadione-dependent H2O2 
formation. INS-1 832/13 cells were treated with 10 mM or 16 mM of the indicated fuel 
in the presence of menadione (10 M) and production of H2O2 was measured as 
described in Methods. Values are expressed as fold change in the rate of H2O2 
formation relative to the cells treated with 2 mM glucose in the absence of menadione 
(control). Data are means ± SD (n=3) and are representative of 2 independent 
experiments.  Asterisks (*) indicate a significant increase from corresponding 2 mM 
control for each fuel.  Pound symbols (#) indicate a significant decrease from control.   
Figure 5.  Mitochondrial inhibitors potentiate menadione-stimulated redox cycling 
in INS-1 832/13 cells.  Cells were treated with glucose (2 mM or 16 mM) and 
menadione (10 M) in the absence or presence of mitochondrial inhibitors cyanide (A) 
or Antimycin A (B).  The rate of production of H2O2 was determined as described in 
Methods. Data are means ± SD (n=3) and are representative of 3 independent 
experiments.   
Figure 6.  Effect of menadione and H2O2 on PMET activity in INS-1 832/13 cells. 
Cells were treated with menadione (A,B) or H2O2 (C,D)  in the presence of 2 mM or 16 
mM glucose and analyzed for reduction of WST-1 (A,C) or ferricyanide (B,D). Data are 
means ± SD (n=3) and are representative of 2 independent experiments.  Pound 
symbols (#) and asterisks (*) indicate significant difference from 2 mM and 16 mM 
glucose-treated samples without menadione or H2O2. 
Figure 7. Dicoumarol and DPI inhibit menadione-mediated H2O2 formation. INS-1 
832/13 cells exposed to 2 or 16 mM glucose were treated with dicoumarol (A) or DPI (B) 
in the presence of 10 M menadione. Rate of H2O2 formation was determined as 
described in Methods. Data are means ± SD (n=3) and are representative of 3 
independent experiments.   
Figure 8.  Glucose protects against H2O2 and menadione-induced toxicity in INS-1 
832/13 cells.  Cells were treated with H2O2 (A) or menadione (10 M) or vehicle control 
(B) in the presence of basal (2 mM) or stimulatory (16 mM) glucose for 6 h.  Cell 
survival was quantified by CellTiter-Blue.  (C) Cells were treated as in (B) and analyzed ACCEPTED MANUSCRIPT
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for viability by trypan blue exclusion after 6 h.  (D) Oxidized and total glutathione was 
measured after 30 min exposure of cells to menadione or vehicle control in the 
presence of basal (2 mM) or stimulatory (16 mM) glucose.   
Figure 9.  Mechanism for menadione-stimulated insulin secretion.  In pancreatic β-
cells, NADH is produced via glycolysis and is re-oxidized by mitochondria (1) and 
plasma membrane electron transport (2).  Treatment with menadione leads to the 
consumption of NADH and NADPH as menadione is reduced by oxidoreductases (3) to 
its semiquinone or hydroquinone form.  These reduced forms chemically react with 
molecular oxygen to produce O2
- and the parent compound, allowing sustained 
production of H2O2 which induces insulin secretion.  Under stimulatory glucose, the rate 
of glycolysis is increased, resulting in greater production of NADH (via glycolysis) and 
NADPH (via pyruvate cycling (4), both of which increase the redox cycling of menadione 
and production of H2O2 to levels that inhibit insulin secretion.   
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Highlights 
Menadione stimulation or inhibition of insulin secretion is dependent upon applied 
glucose levels. 
Menadione-dependent H2O2 production is proportional to applied glucose levels 
Quinone-mediated redox cycling is dependent on glycolysis 